Phase IIB TMB High Pan Tumor Monotherapy
Research payments
$188,489
Through program year 2019, $188,489 in research payments was reported against Phase IIB TMB High Pan Tumor Monotherapy, across 20 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $188,489 | 20 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Aung Naing Houston, TX Named on 2 payments
- Allen Cohn Steamboat Springs, CO Named on 2 payments
- Steven Oday Santa Monica, CA Named on 2 payments
- Donald Richards Tyler, TX Named on 1 payment
- Jeffrey Yorio Austin, TX Named on 1 payment
- Jacqueline Vuky Portland, OR Named on 1 payment
- John Glaspy Los Angeles, CA Named on 1 payment
- Ari Vanderwalde Germantown, TN Named on 1 payment
- Kristi McIntyre Dallas, TX Named on 1 payment
- Matthew Taylor Portland, OR Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.